Trials / Conditions / Primary Peritoneal Carcinosarcoma

Primary Peritoneal Carcinosarcoma

7 registered clinical trials studyying Primary Peritoneal Carcinosarcoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV O NCT06639074	Mayo Clinic	Phase 2
Recruiting	Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity NCT05920798	Mayo Clinic	Phase 1 / Phase 2
Recruiting	APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment NCT04919629	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With NCT04092270	National Cancer Institute (NCI)	Phase 1
Terminated	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors NCT03641287	University of Washington	N/A
Terminated	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cance NCT02364713	Mayo Clinic	Phase 2
Completed	Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707	Mayo Clinic	Phase 1